Skip Ribbon Commands
Skip to main content

Research Platforms

The team is involved in research related to neurocognitive impairments and dementia, focusing on disease biomarkers.

Research Studies:

  • Longitudinal Observational Studies
  • Clinical Trials

Research Platforms:

  • Neuropsychological Assessments
    • Assess global cognition and five other domains including episodic memory, executive function, visuospatial abilities, attention and language
  • Fluid Biomarkers
    • Blood and Cerebrospinal Fluid: Amyloid, Tau, Genetics, Neuroinflammation, Neurodegeneration Markers
  • Neuroimaging
    • Computerised Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)